• Latest Posts

Recursion boosts drug discovery with Cyclica and Valence acquisitions

Interview 2 May 2023

Generative AI in novel drug development

Podcast 28 Apr 2023

Beyond Biotech podcast 43

Australian biopharma Telix banks on AI with Dedicaid acquisition

Can artificial intelligence predict future pandemics?

Expert Advice 18 Apr 2023

Pharmacovigilance – how to deal with the data

ADVERTISEMENT

Adaptyv Bio launches to ‘change protein engineering’

PsychoGenics launches eCube AI platform for drug discovery

In Depth 11 Apr 2023

How to overcome clinical trial challenges

Sofinnova Partners dives into digital medicine, funds new companies

How the microbiome can predict cancer immunotherapy success

Twisted blood vessels reveal cancer treatment success potential

ADVERTISEMENT